Use of clays as drug delivery systems: Possibilities and limitations

被引:517
作者
Aguzzi, C.
Cerezo, P.
Viseras, C.
Caramella, C.
机构
[1] Univ Granada, Fac Farm, Dept Farm & Tecnol Farmaceut, E-18071 Granada, Spain
[2] Univ Pavia, Dept Pharmaceut Chem, I-27100 Pavia, Italy
关键词
clays; special excipients; modified drug release; bioavailability; cation-exchange;
D O I
10.1016/j.clay.2006.06.015
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The need for safe, therapeutically effective and patient-compliant drug delivery systems continuously leads researchers to design novel tools and strategies. Clay minerals are widely used materials in drug products both as excipients and active agents. When administered simultaneously, drug-clay interactions have been observed and studied, but until recently were not considered as a possible mechanism to modify drug release. In recent years, and based on their high retention capacities as well as swelling and colloidal properties, clays have been proposed as very useful materials for modulating drug delivery. This paper first reviews the studies on drug-clay interactions, and then those focused on the applications of natural clays and their semi-synthetic or synthetic derivatives to carry out specific functions in new drug delivery systems. In particular, clays are used to delay and/or target drug release or even improve drug dissolution. Finally, new strategies are reported for increasing drug stability and simultaneously modifying drug delivery patterns through the use of clay minerals. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:22 / 36
页数:15
相关论文
共 193 条
  • [1] Abdel-Mohsen MG, 2001, STP PHARMA SCI, V11, P295
  • [2] Sol-gel transitions of sodium montmorillonite dispersions
    Abend, S
    Lagaly, G
    [J]. APPLIED CLAY SCIENCE, 2000, 16 (3-4) : 201 - 227
  • [3] Influence of dispersion conditions of two pharmaceutical grade clays on their interaction with some tetracyclines
    Aguzzi, C
    Viseras, C
    Cerezo, P
    Rossi, S
    Ferrari, F
    López-Galindo, A
    Caramella, C
    [J]. APPLIED CLAY SCIENCE, 2005, 30 (02) : 79 - 86
  • [4] AGUZZI C, 2005, P 45 S AFI RIM IT, P177
  • [5] Aguzzi C, 2003, P 30 ANN M EXP CONTR
  • [6] AGUZZI C, 2003, P 1 EUF C OPT DRUG D, P136
  • [7] AGUZZI C, 2005, P 1 PHARMS FAIR PHAR
  • [8] Aguzzi C., 2003, P 1 EUFEPS C OPT DRU
  • [9] INFLUENCE OF KAOLIN-PECTIN SUSPENSION ON DIGOXIN BIOAVAILABILITY
    ALBERT, KS
    AYRES, JW
    DISANTO, AR
    WEIDLER, DJ
    SAKMAR, E
    HALLMARK, MR
    STOLL, RG
    DESANTE, KA
    WAGNER, JG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) : 1582 - 1586
  • [10] PHARMACOKINETIC EVALUATION OF A DRUG INTERACTION BETWEEN KAOLIN-PECTIN AND CLINDAMYCIN
    ALBERT, KS
    DESANTE, KA
    WELCH, RD
    DISANTO, AR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (11) : 1579 - 1582